|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
4 |
0.991
|
|
|
vitellogenesis
|
GO:0007296 |
2 |
0.983
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.965
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity involved in g2 m transition of mitotic cell cycle
|
GO:0031660 |
1 |
0.965
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.948
|
|
|
nuclear transcribed mrna poly a tail shortening
|
GO:0000289 |
7 |
0.938
|
|
|
positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:1900153 |
5 |
0.938
|
|
|
positive regulation of mrna 3 end processing
|
GO:0031442 |
5 |
0.930
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.927
|
Human Mouse |
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.872
|
Human Mouse |
|
fat cell differentiation
|
GO:0045444 |
160 |
0.870
|
Mouse |
|
regulation of mrna 3 end processing
|
GO:0031440 |
6 |
0.815
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.799
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.795
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.795
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.749
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.745
|
|
|
negative regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0097201 |
1 |
0.741
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.736
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.727
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.713
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.711
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.707
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.698
|
Human Mouse |
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.696
|
|
|
adipose tissue development
|
GO:0060612 |
25 |
0.695
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.694
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.690
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.690
|
Human Mouse |
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.662
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.655
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.640
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.636
|
|
|
regulation of ovulation
|
GO:0060278 |
3 |
0.614
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.603
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.598
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.598
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.592
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.586
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.585
|
Human Mouse |
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.582
|
|
|
positive regulation of osteoclast differentiation
|
GO:0045672 |
15 |
0.581
|
|
|
regulation of protein autophosphorylation
|
GO:0031952 |
8 |
0.572
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.567
|
|
|
microglial cell activation
|
GO:0001774 |
3 |
0.566
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.561
|
Human Mouse |
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.561
|
|
|
translation
|
GO:0006412 |
93 |
0.534
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.524
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.524
|
|
|
nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:0000288 |
12 |
0.520
|
|
|
placenta development
|
GO:0001890 |
140 |
0.511
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.505
|
Mouse |
|
gtp metabolic process
|
GO:0046039 |
144 |
0.494
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.477
|
|
|
embryonic process involved in female pregnancy
|
GO:0060136 |
7 |
0.474
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.474
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.469
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.465
|
|
|
regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060211 |
4 |
0.460
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.460
|
Mouse |
|
rna 3 end processing
|
GO:0031123 |
20 |
0.459
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.457
|
|
|
cardiac muscle hypertrophy in response to stress
|
GO:0014898 |
10 |
0.425
|
|
|
axon regeneration
|
GO:0031103 |
12 |
0.425
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.418
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.414
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.411
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.396
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.394
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.390
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.385
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.375
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.374
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.374
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.374
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.373
|
|
|
mrna 3 end processing
|
GO:0031124 |
16 |
0.356
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.352
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.352
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.339
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.338
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.332
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.328
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.327
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.320
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.319
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.317
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.316
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.314
|
Mouse |
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.313
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.313
|
|
|
neuron death
|
GO:0070997 |
154 |
0.310
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.309
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.308
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.306
|
Human Mouse |
|
blastocyst development
|
GO:0001824 |
80 |
0.305
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.304
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.302
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.299
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.295
|
Human Mouse |
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.289
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.288
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.287
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.285
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.285
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.282
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.281
|
|
|
glomerular visceral epithelial cell differentiation
|
GO:0072112 |
10 |
0.280
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.279
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.279
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.278
|
Human Mouse |
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.278
|
Mouse |
|
regulation of mrna catabolic process
|
GO:0061013 |
6 |
0.277
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.268
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.266
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.264
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.262
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.262
|
Mouse |
|
positive regulation of mrna metabolic process
|
GO:1903313 |
17 |
0.260
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.250
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.248
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.245
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.244
|
|
|
post embryonic camera type eye development
|
GO:0031077 |
8 |
0.244
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.240
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.240
|
|
|
activation of mapkkk activity
|
GO:0000185 |
1 |
0.237
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.237
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.237
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.236
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.235
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.230
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.223
|
Human Mouse |
|
macromolecule methylation
|
GO:0043414 |
120 |
0.222
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.222
|
|
|
positive regulation of sphingolipid biosynthetic process
|
GO:0090154 |
1 |
0.221
|
|
|
regulation of p38mapk cascade
|
GO:1900744 |
3 |
0.221
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.220
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.216
|
|
|
renal filtration cell differentiation
|
GO:0061318 |
10 |
0.214
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.214
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.212
|
Human Mouse |
|
positive regulation of mrna catabolic process
|
GO:0061014 |
5 |
0.210
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.209
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.209
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.208
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.207
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.206
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.205
|
|
|
monocyte differentiation
|
GO:0030224 |
9 |
0.204
|
|
|
cognition
|
GO:0050890 |
149 |
0.204
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.202
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.202
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.202
|
|
|
response to amphetamine
|
GO:0001975 |
16 |
0.201
|
|
|
lung development
|
GO:0030324 |
164 |
0.198
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.198
|
|
|
response to mineralocorticoid
|
GO:0051385 |
1 |
0.195
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.194
|
|
|
rna processing
|
GO:0006396 |
105 |
0.193
|
|
|
general adaptation syndrome
|
GO:0051866 |
2 |
0.192
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.192
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.191
|
|
|
p38mapk cascade
|
GO:0038066 |
4 |
0.188
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.187
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.187
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.186
|
|
|
adrenal cortex development
|
GO:0035801 |
2 |
0.185
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.185
|
|
|
associative learning
|
GO:0008306 |
61 |
0.184
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.183
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.182
|
|
|
positive regulation of transcription from rna polymerase i promoter
|
GO:0045943 |
3 |
0.180
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.179
|
|
|
negative regulation of ovulation
|
GO:0060280 |
1 |
0.179
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.178
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.178
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.176
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.175
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.174
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.174
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.173
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.171
|
|
|
adrenal cortex formation
|
GO:0035802 |
2 |
0.169
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.169
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.169
|
|
|
cellular response to follicle stimulating hormone stimulus
|
GO:0071372 |
1 |
0.169
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.167
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.167
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.166
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.165
|
|
|
labyrinthine layer morphogenesis
|
GO:0060713 |
21 |
0.163
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.161
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.160
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.159
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.158
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.156
|
Mouse |
|
glomerular epithelial cell differentiation
|
GO:0072311 |
10 |
0.155
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.154
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.154
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.154
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.153
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.149
|
|
|
response to camp
|
GO:0051591 |
14 |
0.149
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.148
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.148
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.147
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.147
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.147
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.146
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.146
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.145
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.145
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.143
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.143
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.143
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.142
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.141
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.141
|
Mouse |
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.139
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.136
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.136
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.135
|
|
|
ossification
|
GO:0001503 |
216 |
0.135
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.135
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.134
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.133
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.133
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.133
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.133
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.133
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.132
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.130
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.129
|
|
|
nuclear transcribed mrna catabolic process
|
GO:0000956 |
16 |
0.128
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.128
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.126
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.126
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.126
|
|
|
osteoblast proliferation
|
GO:0033687 |
18 |
0.125
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
14 |
0.125
|
|
|
intussusceptive angiogenesis
|
GO:0002041 |
2 |
0.125
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.125
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.124
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.124
|
|
|
chorio allantoic fusion
|
GO:0060710 |
8 |
0.124
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.123
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.123
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.123
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.121
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.121
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.121
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.121
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
22 |
0.119
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.119
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.119
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.118
|
|
|
pallium development
|
GO:0021543 |
120 |
0.118
|
|
|
erythrocyte maturation
|
GO:0043249 |
6 |
0.116
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.116
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.114
|
|
|
neuron projection regeneration
|
GO:0031102 |
14 |
0.114
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.113
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.113
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.113
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.113
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.113
|
|
|
cellular response to fluid shear stress
|
GO:0071498 |
4 |
0.112
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.112
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.110
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.110
|
|
|
embryonic placenta morphogenesis
|
GO:0060669 |
25 |
0.110
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.110
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.110
|
|
|
type i pneumocyte differentiation
|
GO:0060509 |
7 |
0.109
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.109
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.108
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.108
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.107
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.107
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.107
|
|
|
negative regulation of peptidyl serine phosphorylation
|
GO:0033137 |
10 |
0.106
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.106
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.106
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.106
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.105
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.104
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.104
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.103
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.103
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.102
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.102
|
|
|
rhombomere 5 formation
|
GO:0021666 |
1 |
0.102
|
|
|
liver development
|
GO:0001889 |
66 |
0.102
|
|
|
cranial nerve formation
|
GO:0021603 |
4 |
0.101
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.101
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.099
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.098
|
|
|
learning
|
GO:0007612 |
98 |
0.098
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.098
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.098
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.097
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.097
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.097
|
Human Mouse |
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.096
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.096
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.096
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.095
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.095
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.095
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.093
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.093
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.093
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.092
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.092
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.092
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.091
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.090
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.090
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.090
|
|
|
response to drug
|
GO:0042493 |
75 |
0.090
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.090
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.090
|
|
|
neuron maturation
|
GO:0042551 |
29 |
0.090
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.090
|
|
|
regulation of translation ncrna mediated
|
GO:0045974 |
2 |
0.089
|
|
|
negative regulation of metanephric glomerulus development
|
GO:0072299 |
1 |
0.089
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.089
|
Human Mouse |
|
brain segmentation
|
GO:0035284 |
3 |
0.089
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.088
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.088
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.088
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.088
|
|
|
cellular response to antibiotic
|
GO:0071236 |
4 |
0.087
|
|
|
regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:1900151 |
5 |
0.087
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.087
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.087
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.087
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.086
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.086
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.086
|
|
|
macrophage activation
|
GO:0042116 |
27 |
0.085
|
|
|
negative regulation of protein kinase activity by regulation of protein phosphorylation
|
GO:0044387 |
2 |
0.085
|
Mouse |
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.084
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.084
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.084
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.083
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.083
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.083
|
Human Mouse |
|
spongiotrophoblast layer development
|
GO:0060712 |
15 |
0.083
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.083
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.082
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.082
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.081
|
|
|
regulation of histone deacetylation
|
GO:0031063 |
12 |
0.081
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.081
|
Human Mouse |
|
transformed cell apoptotic process
|
GO:0006927 |
3 |
0.080
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.079
|
|
|
mrna destabilization
|
GO:0061157 |
4 |
0.079
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.078
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
27 |
0.078
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.078
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.077
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.077
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.077
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.076
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.076
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.076
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.076
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.076
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.076
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.076
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.074
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.074
|
|
|
fertilization
|
GO:0009566 |
127 |
0.074
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.073
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.073
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.073
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.073
|
Human Mouse |
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.073
|
Human Mouse |
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.072
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.072
|
|
|
positive regulation of endothelial cell proliferation
|
GO:0001938 |
17 |
0.072
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.072
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.072
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.072
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.072
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.072
|
|
|
response to ischemia
|
GO:0002931 |
14 |
0.071
|
|
|
vestibular reflex
|
GO:0060005 |
4 |
0.071
|
|
|
cation transport
|
GO:0006812 |
399 |
0.071
|
|
|
nerve development
|
GO:0021675 |
67 |
0.070
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.070
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.070
|
|
|
rhombomere 5 development
|
GO:0021571 |
4 |
0.069
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.069
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.068
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.068
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.068
|
|
|
central nervous system projection neuron axonogenesis
|
GO:0021952 |
21 |
0.068
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.068
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.067
|
|
|
histone modification
|
GO:0016570 |
159 |
0.067
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.067
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.067
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.067
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.066
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.066
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.066
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.066
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.066
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.065
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.065
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.065
|
|
|
smad protein signal transduction
|
GO:0060395 |
21 |
0.065
|
|
|
positive regulation of mrna processing
|
GO:0050685 |
16 |
0.064
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.064
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.064
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.064
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.063
|
|
|
renal system development
|
GO:0072001 |
225 |
0.063
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.063
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.063
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.062
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.062
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.062
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.062
|
|
|
rna interference
|
GO:0016246 |
2 |
0.062
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.061
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.061
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.061
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.061
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
26 |
0.061
|
|
|
positive regulation of podosome assembly
|
GO:0071803 |
3 |
0.061
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.061
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.061
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.060
|
|
|
synaptic growth at neuromuscular junction
|
GO:0051124 |
6 |
0.060
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.060
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.060
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.060
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.059
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.059
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.059
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.059
|
|
|
transcription from rna polymerase i promoter
|
GO:0006360 |
13 |
0.059
|
|
|
negative regulation of metanephric glomerular mesangial cell proliferation
|
GO:0072302 |
1 |
0.059
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.059
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.059
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.059
|
|
|
regeneration
|
GO:0031099 |
38 |
0.059
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.059
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.058
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.058
|
|
|
negative regulation of viral transcription
|
GO:0032897 |
3 |
0.058
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.057
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.057
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.057
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.057
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.057
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.057
|
|
|
protein kinase c signaling
|
GO:0070528 |
7 |
0.056
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.056
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.056
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.056
|
|
|
response to amine
|
GO:0014075 |
16 |
0.056
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.055
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.055
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.055
|
|
|
cellular response to topologically incorrect protein
|
GO:0035967 |
25 |
0.055
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.055
|
|
|
cellular response to hypoxia
|
GO:0071456 |
17 |
0.055
|
|
|
response to organophosphorus
|
GO:0046683 |
22 |
0.055
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.054
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.054
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.054
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.054
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.054
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.054
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.054
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.053
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.053
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.053
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.053
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.053
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.053
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.052
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
16 |
0.052
|
|
|
regionalization
|
GO:0003002 |
337 |
0.052
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.052
|
|
|
response to cycloheximide
|
GO:0046898 |
1 |
0.052
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.052
|
Mouse |
|
response to catecholamine
|
GO:0071869 |
4 |
0.051
|
|
|
regulation of ceramide biosynthetic process
|
GO:2000303 |
1 |
0.051
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
3 |
0.051
|
|
|
cell growth
|
GO:0016049 |
130 |
0.051
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.051
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.050
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.050
|
|